Advertisement

Topics

PharmaKey B.V. Company Profile

22:19 EST 13th December 2018 | BioPortfolio

The founder of PharmaKey has invented a novel approach towards modification of protein-hormones (cytokines). This novel approach is based on a chemical modification platform technology, which resulted in three synergetic interactive platform applications. These applications are the basis for novel concepts in protein drug design and development, which resulted in patents so far in Australia and Europe.

Location

P/O-Box 30230
Almere
1303AE
Netherlands

Contact

Phone: 31 (0) 70 3452 962
Fax: 31 (0) 84 2331 797
Email: prins@pharmakey.nl


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

PharmaKey B.V.

The founder of PharmaKey has invented a novel approach towards modification of protein-hormones (cytokines). This novel approach is based on a chemical modification platform technology, which resulted...

More Information about "PharmaKey B.V." on BioPortfolio

We have published hundreds of PharmaKey B.V. news stories on BioPortfolio along with dozens of PharmaKey B.V. Clinical Trials and PubMed Articles about PharmaKey B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PharmaKey B.V. Companies in our database. You can also find out about relevant PharmaKey B.V. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record